SZT2 and cancer: SZT2 specifically represses mTORC1 during fasting, thus, SZT2-deficiency mimics overnutrition-induced mTORC1 elevation, which is a chronic condition associated with common human diseases, including obesity, diabetes, cancer, and other aging-related diseases (1).